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Abstract
Recent studies have demonstrated that human stearoylCoA desaturase-1 (SCD1), a D9-desaturase that converts saturated
fatty acids (SFA) into monounsaturated fatty acids, controls the rate of lipogenesis, cell proliferation and tumorigenic
capacity in cancer cells. However, the biological function of stearoylCoA desaturase-5 (SCD5), a second isoform of human
SCD that is highly expressed in brain, as well as its potential role in human disease, remains unknown. In this study we
report that the constitutive overexpression of human SCD5 in mouse Neuro2a cells, a widely used cell model of neuronal
growth and differentiation, displayed a greater n-7 MUFA-to-SFA ratio in cell lipids compared to empty-vector transfected
cells (controls). De novo synthesis of phosphatidylcholine and cholesterolesters was increased whereas phosphatidyleth-
anolamine and triacylglycerol formation was reduced in SCD5-expressing cells with respect to their controls, suggesting
a differential use of SCD5 products for lipogenic reactions. We also observed that SCD5 expression markedly accelerated the
rate of cell proliferation and suppressed the induction of neurite outgrowth, a typical marker of neuronal differentiation, by
retinoic acid indicating that the desaturase plays a key role in the mechanisms of cell division and differentiation. Critical
signal transduction pathways that are known to modulate these processes, such epidermal growth factor receptor
(EGFR)Akt/ERK and Wnt, were affected by SCD5 expression. Epidermal growth factor-induced phosphorylation of EGFR, Akt
and ERK was markedly blunted in SCD5-expressing cells. Furthermore, the activity of canonical Wnt was reduced whereas
the non-canonical Wnt was increased by the presence of SCD5 activity. Finally, SCD5 expression increased the secretion of
recombinant Wnt5a, a non-canonical Wnt, whereas it reduced the cellular and secreted levels of canonical Wnt7b. Our data
suggest that, by a coordinated modulation of key lipogenic pathways and transduction signaling cascades, SCD5
participates in the regulation of neuronal cell growth and differentiation.
Citation: Sinner DI, Kim GJ, Henderson GC, Igal RA (2012) StearoylCoA Desaturase-5: A Novel Regulator of Neuronal Cell Proliferation and Differentiation. PLoS
ONE 7(6): e39787. doi:10.1371/journal.pone.0039787
Editor: Masaru Katoh, National Cancer Center, Japan
Received January 11, 2012; Accepted May 30, 2012; Published June 22, 2012
Copyright:  2012 Sinner et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported in part by funds from the School of Environmental and Biological Sciences and the Charles and Johanna Busch Foundation,
Rutgers University, and a Hatch grant from the U.S. Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: igal@aesop.rutgers.edu
¤ Current address: Clarassance, Inc., Rockville, Maryland, United States of America
Introduction
As part of the development of the central nervous system,
neuronal cells are required to coordinately expand their popula-
tion and integrate a functional network by connecting through
growing dendrites and axons, cell prolongations that are collec-
tively denominated neurites. Neurite outgrowth is widely em-
ployed as a typical marker for assessing differentiation in cultured
neuronal cells such as PC12 rat pheochromocitoma cells and
Neuro-2a mouse neuroblastoma cells [1,2]. Although the mechan-
isms by which neuronal cells control the timing of cell proliferation
and differentiation are still poorly understood, animal and cell-
based studies have shown that a number of extrinsic factors,
including growth factors and cytokines, such as epidermal growth
factor (EGF), platelet-derived growth factor, and brain-derived
neurotrophic factor, have crucial influence on the functional fate
of neuronal cells [2,3]. The binding of these factors to plasma
membrane receptors triggers the activation of central signal
transduction cascades, including MAPK (ERK1/2), Akt and Src,
which will initiate the transcriptional program needed for neuronal
differentiation [3–5].
In addition to the aforementioned neurotrophic factors, Wnt
proteins, a family of secreted proteins that modulates a myriad of
cellular and organismal functions, including cellular proliferation,
axis formation and organogenesis [6,7], are key regulators of
neuronal differentiation [8]. Binding of Wnt ligands to their
receptor complex, consisting of members of Frizzled and low-
density lipoprotein family LRP5 and LRP6, activates two main
cascades of intracellular signals, the canonical b-catenin/TCF
pathway, and the less understood non-canonical Wnt signaling
which is independent of b-catenin. This signaling includes the
planar cell polarity-convergent extension (PCP-CE) pathway, via
Jun N-terminal kinase (jnk), Rho and Rac mediators [9,10], and
the Wnt/Calcium pathway which signals through Dvl to induce
calcium influx and the activation of protein kinase C (PKC) and
calcium/calmodulin-dependent protein kinase II (CaMKII) [11].
Wnt proteins have been shown to participate in the mechanisms of
cell replication and differentiation in neurons, both in brain and in
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39787culture cells, by activating both signaling branches of Wnt
pathways [8], but the mechanisms by which these signals regulate
the timing of these processes is unclear.
The morphological changes that take place during the process
of neuronal differentiation, such as neurite outgrowth, axon
development and branching of neurite prolongations, also require
a finely tuned regulation of lipid biosynthesis, especially the
formation of new membrane phospholipids [12]. In mammalian
cells, the biosynthesis of acyl-containing lipids employs saturated
(SFA) and monounsaturated fatty acids (MUFA) as preferential
substrates. The abundance of these fatty acids is determined, in
great part, by the activity of StearoylCoA desaturases (SCD), key
lipogenic enzymes that catalyze the conversion of SFA into
MUFA. These fatty acid species, particularly MUFA, appear to be
essential components for fetal brain development. Data from
experiments performed in rats indicate that exogenous MUFA and
SCD-derived MUFA are critical neurotrophic factors implicated
in the modulation of axogenesis in brain [13,14]. However, the
potential implication of human SCDs in the mechanisms of
neurogenesis and neuronal differentiation has remained under-
studied. Human tissues express two SCD variants, SCD1 and
SCD5 [15]. Our lab and others have reported that SCD1, a D9-
desaturase isoform present in most mammalian tissues, plays a key
role in the regulation of lipogenesis, cell cycle and programmed
cell death in human normal and cancer cells [16–20]. SCD5,
a SCD isoform that was thought to be exclusive of primates but is
also found in bovines, dogs and birds, is uniquely expressed in fetal
brain, as well as in adult brain and pancreas [21–24], a distribution
pattern that suggest that this enzyme may be implicated in critical
neural functions. In this regard, it was recently reported that the
expression of SCD5 mRNA was elevated in the brain of patients
with Alzheimer’s disease [25].
Unlike SCD1, the regulation and functional roles of SCD5 in
human cells and tissues, especially in brain cell biology, have not
been described to date. In the present study we show that
constitutive expression of human SCD5 in mouse Neuro2a cells,
a well-characterized cell model of neuronal differentiation [5],
promotes a greater n-7MUFA-to-SFA ratio in total cell lipids and
modifies the pattern of de novo synthesis of lipids. Concomitantly,
SCD5 activity stimulated cell proliferation whereas it significantly
suppressed the process of retinoic acid-induced differentiation of
Neuro2a cells into mature neurons, suggesting a role for the
desaturase in regulating the balance between cell expansion and
differentiation of neuronal cells. We also provide evidence that
signal transduction pathways that modulate these processes, such
as epidermal growth factor receptor (EGFR)Akt/ERK and Wnt,
are targeted for regulation by SCD5. Our data offer new insight
into the role of SCD5 as a key factor in the coordinated regulation
of lipogenic and signaling events that determine the biological fate
of the neuronal cell.
Materials and Methods
Materials
Mouse neuroblastoma Neuro2a cells, WS-1 human normal
fibroblasts, SH-SyS5 and human neuroblastoma cells were
obtained from the American Type Culture Collection (Rockville,
MD, USA). Dulbecco’s modification of Eagle’s medium (DMEM)
with L-glutamine, MEM vitamin mixture and MEM nonessential
amino acid solution were from Mediatech Cellgro (Manassas, VA,
USA). Minimum Essential Medium (MEM) containing Earle’s
salts and L-glutamine, glucose free DMEM, phenol red free
MEM, trypsin-EDTA solution and Lipofectamine
TM 2000 trans-
fection reagent were purchased from Invitrogen Corporation
(Carlsbad, CA, USA). Heat-inactivated fetal bovine serum, crystal
violet, protease and phosphatase inhibitor cocktail 2, fatty acid free
bovine serum albumin, monoclonal anti b-actin antibody, and
dimethyl sulphoxide (DMSO) were from Sigma-Aldrich (St. Louis,
MO, USA). Nitrocellulose membrane, HPLC grade solvents,
phosphate-buffered solution without calcium and magnesium and
other cell culture supplies were obtained from Thermo Fisher
Scientific (Pittsburgh, PA, USA). Pure fatty acid standards were
purchased from Sigma-Aldrich or Nu-Check Prep (Elysian, MN,
USA). Anti phospho-ERK1/2, antiphospho-EGFR (Tyr1068 and
Tyr1086), antiphospho-Akt (S473) and total EGFR antibodies
were from Cell Signaling Technology Inc (Danvers, MA, USA).
GAPDH, Akt, ERK, HRP-conjugated anti mouse and anti rabbit
IgG were from Santa Cruz Biotechnologies (Santa Cruz, CA,
USA). Anti-V5 antibody was from Millipore (Billerica, MA).
Luciferase and Renilla assay systems were obtained from Promega
(Madison, WI). PathDetect c-Jun kinase reporter system was from
Stratagene, Inc (Santa Clara, CA). D-[U-
14C]glucose was
purchased from American Radiolabeled Chemicals, Inc (St. Louis,
MO, USA). Full-range rainbow molecular weight marker was
from GE Healthcare Bio-Sciences Corp (Piscataway, NJ, USA).
BCA Bradford protein assay kit and super signal West Pico
chemiluminescent substrate were from Pierce (Rockford, IL,
USA). Human SCD5 (,37 kDa) was detected with a specific
antibody kindly donated by Dr. Brent Rupnow, Bristol-Myers
Squibb. This antibody was raised by immunizing rabbits with
fusion proteins containing an SCD5-specific peptide sequence
(MPGPATDAGKIPFCDAKEEIRAGLESSEGG) [20] and does
not cross-react with the human SCD1 isoform (,41 kDa) (Kim &
Igal, unpublished observations).
Cell culture
Unless otherwise stated, cells were cultured in DMEM
supplemented with 10% FBS, penicillin (100 U/ml), streptomycin
(10 mg/ml), 1% non essential amino acids and 1% MEM vitamin
solution (growing medium). Cells were grown at 37uC, 5% CO2,
and 100% humidity.
Plasmids
The following constructs were previously used and described:
pcDNA6 carrying the gene encoding human b-catenin with the
S37A mutation [b-catenin (S37A)] [26], pcDNA6 V5 mSox4
pcDNA6 V5 mSox17, pcDNA6hTCF4, pcDNA V5 DEST
hWnt7bV5 [27] was kindly provided by the Stem cell core
CCHMC, pcDNA6 V5 mouse Wnt5a was provided by Dr Aaron
Zorn, Cincinnati Children’s Hospital Medical Center. TCF-
luciferase reporter plasmids super8x TOP-flash and super8x FOP-
flash [28] were generously provided by Randall Moon, University
of Washington (Addgene plasmids 12456 and 12457). Human
SCD5 cDNA cloned into a pcDNA
TM4/TO/myc-His expression
vector was generously donated by Dr. Brent Rupnow, Bristol-
Myers Squibb.
Generation of human SCD5-expressing Neuro2a cells
Neuro2a cells, grown in 6-well plates up to 50% confluence,
were washed twice with serum-free Opti-MEM and then
transfected with 2.5 mg of either human SCD5 cDNA cloned in
a pCDNA4/TO expression vector (Invitrogen), or empty plasmid
(controls) plus 10 ml of LipofectAMINE 2000
TM in 0.5 ml of Opti-
MEM plus 20% FBS. After 5 h incubation, medium was replaced
by 10%FBS MEM and transfected cells were grown for an
additional 24 h. Then, positive SCD5-expressing cells (SCD5 cells)
and empty vector-transfected cells (pCDNA4 cells) were selected
by culturing the cells in 10% FBS, MEM containing zeocin
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by Western blot was described below.
Cell lipid labeling, extraction and analysis
De novo synthesis of lipids in SCD5-expressing and control
Neuro2a cells was assessed by the incorporation of [U-
14C]glucose
into cell lipids. Cells were incubated with 0.5 mCi/dish with
[U-
14C]glucose in 10%FBS DMEM for 16h. At the end of the
labeling period, radioactive media was removed and cells were
washed twice with 0.5% BSA in ice-cold PBS. Total cell lipids
were then extracted following the procedure of Bligh & Dyer [29].
Total phospholipids and individual neutral lipids were separated
by one-dimensional thin-layer chromatography (TLC) as de-
scribed in Scaglia et al. [14]. Lipid spots on the TLC plate were
stained with iodine vapors, and polar and neutral lipid fractions
were scraped and their radioactivity counted in a liquid scintil-
lation counter. The amount of [
14C]tracer incorporated into lipids
was normalized to cellular protein content of cells grown in
parallel Petri dishes.
Fatty acid analysis
Following organic extraction of total cell lipids and addition of
40 mg of heptadecanoic acid as internal standard, lipids were
saponified to free fatty acids and then derivatized to their 2-
nitrophenylhydrazide (2-NPH) derivatives as described in detail
previously [30]. The derivatized compounds were then recon-
stituted with 150 ml methanol for analysis of fatty acids as their 2-
NPH derivatives by high performance liquid chromatography
(HPLC) using the method of Miwa et al. [31] as optimized by
Henderson and Tuazon [30]. The relative abundance of 22 fatty
acids in tissue lipid extracts were calculated as molar percentages
based upon the following fatty acid external standards: Myristic
acid (14:0), Myristoleic acid (14:1n-5), Myristelaidic acid (trans-
14:1n-5), Palmitic acid (16:0), Palmitoleic acid (16:1n-7), Palmite-
laidic acid (trans-16:1n-7), Stearic acid (18:0), Oleic acid (18:1n-9),
Elaidic acid (trans-18:1n-9), cis-Vaccenic acid (18:1n-7), trans-
Vaccenic acid (trans-18:1n-7), Linoleic acid (18:2n-6), Linoelaidic
acid (trans, trans-18:2n-6), a-Linolenic acid (18:3n-3), c-Linolenic
acid (18:3n-6), Arachidic acid (20:0), Homo-c-Linolenic acid
(20:3n-6), Arachidonic acid (20:4n-6), Eicosapentaenoic acid
(20:5n-3), Docosatetraenoic acid (22:4n-6), Docosapentaenoic acid
(22:5n-3), Docosahexaenoic acid (22:6n-3).
Induction of neuronal differentiation
Neuro2a cells, stable expressing SCD5 or empty expression
plasmid, were plated at 5610
4 cells per 60-mm cell culture dish in
10%FBS DMEM and allowed to attach to the dish for 16 h.
Media was then removed and cells were incubated with
differentiation media (DMEM supplemented with 2%FBS and
20 mM trans-retinoic acid (RA)) for up to 96 h. A control group
(undifferentiated cells) was maintained in 10%FBS DMEM. Cell
bearing neurites equal to or longer than the cell diameter were
considered to be differentiated cell. The experiment was
performed in triplicate dishes and repeated three times with
similar results. Data were expressed as percentage of total cells that
were neurite-bearing.
Determination of cell proliferation rate
Cells were seeded in 12 well plates (1.4610
4 cells per well).
Twenty four hours later, the monolayers were rinsed with PBS and
cells were grown in 10%FBS DMEM for up to 96 h. The media
was changed every 48 h. Cellular proliferation was estimated by
crystal violet staining following the procedure described by Menna
et al. [32], with modifications. Briefly, cells were fixed with
methanol, stained with 0.1% crystal violet in distilled water for
30 min and rinsed three times with water. The dye in the stained
cells was solubilized in 10% methanol, 5% acetic acid solution and
quantified by spectrophotometry at 580 nm. The optical density
value of a blank well was subtracted in each case. The values at
different time points were normalized to the data at 24 h after
seeding to avoid differences due to disparity in cell adhesion
efficiency or cell death.
Determination of canonical and non-canonical Wnt
activit
HEK 293T were plated into 24-well plates a day prior to
transfection to yield density of 70% at transfection. Canonical Wnt
signaling was monitored by TOP-flash assay. Cells were
transfected with the following constructs: TOP-flash plasmid
(50 ng), Fop flash plasmid (50 ng), which contains mutated
binding sites for TCF and serves as a negative control of TOP-
flash plasmid; renilla plasmid (50 ng) as a transfection control, the
gene encoding a stabilized form of b-catenin (S37A) (100 ng), and
the SCD5 construct (75 to 150 ng) by using Fugene 6 (Roche).
The total amount of DNA was kept constant by adding empty-
vector DNA. At 48 h post transfection cells were harvested and
luciferase activity was measured as previously described [33].
Transfection efficiency was normalized using renilla luciferase
activity from the control plasmid. Results are representative of
three independent experiments. Non-canonical Wnt activity was
measured by JNK activity using the PathDetect c-Jun kinase
reporter system (Stratagene, Inc.). HEK 293T cells were
transfected with the pFR-luc reporter plasmid (250 ng), the
pGAL4-c-Jun-N-term vector (12.5 ng), and either pcDNA3/
Wnt5a, (which serves as positive control by inducing JNK activity),
pcDNA3/SCD5, or pcDNA3. The pGAL4DBD was used as
a negative control of pGAL4-c-Jun- N-term vector since it does
not contain activation domain. The pFC MEKK (12.5 ng) was
used as positive control for the assay since it phosphorylates the
transreporter thus inducing luciferase synthesis. Luciferase activity
was measured as described before.
Analysis of synthesis and secretion of Wnt proteins
In order to analyze the intracellular and secreted levels of
Wnt5a (,42 kDa) and Wnt7 b (,39 kDa), Neuro2a cells over-
expressing SCD5 (SCD5) and control Neu2a were plated into 24-
well plates 24 hs prior to transfection and then were transiently
transfected with Wnt tagged constructs (mWnt5aV5 or
hWnt7myc). Groups of cells were transfected with either Sox17
or TCF cDNA and employed as controls of protein synthesis.
Twelve hours post-transfection culture media was replaced with
150 ml serum free media. After 24 h incubation, cell media and
cells were collected and processed for SDS-PAGE. Western blots
were performed using anti V5, anti myc and anti GAPDH
antibodies. Experiments were performed using three to four
replicates and repeated at least twice.
Immunoblotting
After corresponding treatments, cells were rinsed with ice cold
PBS, scraped in cold hypotonic lysis buffer (20 mM Tris-HCl pH
7.5, 10 mM NaF, 1mM EDTA, plus protease and phosphatase
inhibitor cocktails) and homogenized by sonication in ice-water
bath. Fifty mg of total cellular proteins were resolved by SDS-
PAGE and transferred onto a nitrocellulose membrane. After
blocking, the membranes were incubated overnight at 4uC or for
2 h at room temperature with primary antibody. Horseradish
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dilutions. Proteins on the membrane were detected using a West
Pico chemiluminescence detection kit and photographed with
a ChemiDoc (BioRad) digital image system. Immunoblots were
repeated at least three times with essentially the same results.
Determination of cellular protein
Total cellular protein content was measured by Bradford
method, using BSA as a standard.
Statistical analysis
Results from a representative experiment with at least 3 samples
per experimental group are presented as means 6 S. D. Statistical
significance of the data was determined by Student’s t-test.
Results
Expression of human SCD5 gene in Neuro2a cells
increases the n-7 MUFA-to-SFA ratio
To begin assessing the metabolic and biological implications of
SCD5 expression, we established a cell model of SCD5 expression
in mouse neuroblastoma Neuro2a cells, which do not naturally
express SCD5. This cell model serves a two-fold purpose: it allows
us to investigate the physiological and metabolic roles of human
SCD5, a SCD isoform that has remained unexplored; and also to
determine a potential role of this desaturase in the processes of
neuronal cell growth and differentiation. Thus, cells were stably
transfected with SCD5 cDNA (SCD5 cells) or with empty
pCDNA4 expression vector (pCDNA4 cells) and subjected to
positive selection with puromycin for two weeks. As we expected,
ectopic expression of SCD5 protein in transfected cells with the
SCD5 construct (Figure 1A) was verified in cell homogenates by
Western Blot analysis. The fatty acid analysis by HPLC suggests
that the ectopic SCD5 was functionally active in the neuronal cells
since expression of SCD5 markedly altered the balance MUFA-to-
SFA, increasing the ratios n-7 palmitoleic acid (16:1)/palmitic acid
(16:0) (Figure 1B) and cis-vaccenic acid (18:1) + palmitoleic acid/
palmitic acid by ,20–25% (Figure 1C). The altered fatty acid
ratios were the result of a significant increase in palmitoleic acid
(mol%=5.4060.58, controls; 7.0560.18, SCD5 cells, p,0.01 by
Student’s t test), and a parallel reduction, albeit slight, in palmitic
acid (mol%=28.6960.25, controls; 27.3160.25, SCD5 cells,
p,0.03 by Student’s t test). Levels of oleic acid (18:0) and stearic
acid were not significantly changed by SCD5 overexpression
(mol% oleic acid=27.2263.28, controls; 28.4760.22, SCD5;
mol% stearic acid=15.6361.28, controls; 14.6160.28, SCD5),
which caused the balance between the n-9 MUFA/SFA to remain
essentially unchanged (Figure 1D), suggesting that SCD5 expres-
sion in Neuro2a cells specifically induces the production of n-7
MUFA.
Alteration of glucose-mediated lipid synthesis by SCD5
expression. Normal proliferating cells and cancer cells activates
lipogenesis, particularly phospholipid formation, in order to cope
with the metabolic requirements of cell proliferation [15,33,34]. In
these cells, the degree of activation of SCD1 is directly linked to
the rate of lipid synthesis [16,17]. The participation of human
SCD5 in the modulation of lipogenesis has not been addressed to
date. In order to investigate the mechanisms of metabolic
regulation by SCD5 in mammalian cells, we studied the effect of
constitutive expression of SCD5 on glucose-mediated lipid bio-
synthesis in proliferating Neuro2a cells. Cells were incubated with
[U-
14C]glucose for 16 h and the levels of [
14C]labeled lipids were
determined. The incorporation of carbons from the [
14C]glucose
into total lipids was found unmodified by the expression of ectopic
SCD5 (data not shown). [
14C]label was mostly incorporated into
phospholipids, particularly phosphatidylcholine (PC) and phos-
phatidylethanolamine (PE) (Figure 2A), as well as in lower
amounts in phosphatidylinositol and phosphatidylserine (not
shown). Biosynthesis of PC was significantly, albeit slightly,
elevated whereas PE levels were decreased in SCD5-cells
compared to their controls. Neutral lipids triacylglycerol (TAG)
and cholesterolesters (CE) represented a quantitatively minor
fraction of [
14C]labeled-lipids (Figure 2B). The incorporation of
radiolabeled glucose into TAG was significantly reduced (,20%),
whereas the presence of [
14C]tracer in CE was increased by
,85% in SCD5-expressing cells with respect to controls. Taken
together, these findings suggest that SCD5 activity participates in
the control of de novo lipid synthesis in neuronal cells. Also, the
observation that SCD5 expression induces a differential partition
of [
14C]glucose label into lipid species indicates that it affects the
functional segregation of fatty acids into different lipogenic routes.
Expression of human SCD5 in Neuro2a cells reduces
neuronal differentiation and increases cell
proliferation. Regulation of lipid metabolism is critical for
the balance between cell replication and differentiation that
determine the fate of neuronal cells [5]. Given the fact that stably
expressed SCD5 markedly alters fatty acid composition and lipid
biosynthesis, we determined whether neuronal cell growth and
differentiation were affected by these modifications in lipid
metabolism. Neuro2a cells, expressing SCD5 and controls, were
incubated in 2%FBS DMEM plus 10 mM RA for 96 h to promote
neuronal maturation. A group of cells was placed in 10%FBS
DMEM and they were considered undifferentiated controls. It was
observed that induction of differentiation resulted in a significant
development of neurites in pCDNA4 control cells (Figure 3A, left
panel), with over 80% of cells displaying neurite outgrowth after
a 48 h incubation (Figure 3B). Remarkably, in cells expressing
human SCD5 neuritogenesis was notably suppressed (Figure 3A,
right panel), with only ,20% of cells showing neurite prolonga-
tions (Figure 3B). After 96h of differentiation, all plasmid-
transfected control cells exhibited long branching neurite prolon-
gations, whereas a majority of SCD5-cells showed fewer and
shorter neurite outgrowths (data not shown). We also determined
the presence of bIII-tubulin, a typical early marker of neuronal
differentiation [35], upon incubation with 10 mM RA for 24 and
48 h. In absence of RA, SCD5 and control cells showed low levels
of bIII-tubulin (Figure 3C). Twenty four hours after induction of
differentiation, bIII-tubulin markedly increased in control cells,
remaining elevated after 48 h of RA treatment. Although bIII-
tubulin slightly increased in SCD5 cells at 24 and 48 h of
differentiation, the levels of this protein were significantly more
reduced than in control cells. Altogether, these results indicate the
significant impact of SCD5 activity on the program of neuronal
differentiation.
To further delineate the potential functional relationship
between SCD5 and the program of neuronal differentiation, we
examined whether retinoic acid would affect the levels of SCD5 in
human cells. We observed that treatment with concentrations of
retinoic acid for up to 10 mM did not modify the content of SCD5
enzyme in WS-1 normal human skin fibroblasts cells (Figure 4A).
Incubation of SH-SY5Y human neuroblastoma cells with 10 mM
RA for 96 h, a treatment that leads to induction of neuronal
differentiation [36], also failed to change the levels of SCD5
protein in these cells (Figure 4B). Together with data from the
differentiation experiments, these results suggest that although
SCD5 expression may not be targeted by the differentiation
program, the activity of the desaturase may be crucial for its
execution.
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SCD5-overexpressing Neuro2a cells was accompanied by other
modifications in the biological phenotype of these cells, empty
plasmid-transfected control and SCD5 cells were tested for cell
proliferation. The presence of SCD5 activity in Neuro2a cells
resulted in a marked increase (80–100%) in the cellular pro-
liferation rate (Figure 5A), strongly suggesting that the higher
MUFA-to-SFA ratio in these cells propelled the mitogenic process.
As expected, incubation of SCD5 expressors and their controls
with 10 mM retinoic acid for 24 h induced a profound reduction in
cell proliferation (Figure 5B), although this decreasing effect was
attenuated, albeit slightly, in the SCD5-expressing cells as
compared with controls. Interestingly, incubations with 10 mM
RA for 1h and 48 h greatly reduced the levels of cyclin D1, a key
protein that propels cell cycle [37], in control Neuro2a cells, but
this decreasing effect was much more attenuated in SCD5-
expressing cells (Figure 5C). Altogether, the results of these
experiments indicate that SCD5 activity controls neuronal fate by
suppressing neuronal differentiation while concomitantly activat-
ing cell proliferation, likely by accelerating the progression of cell
cycle.
Expression of SCD5 alters the EGF-dependent signaling
mechanism. A key aspect of our hypothesis is that SCD5
activity, by producing specific changes in lipid molecular species,
may modulate plasma membrane-resident signaling platforms that
control cell proliferation and differentiation. As mentioned above,
EGFRAkt/ERK signaling cascade is one of the most ubiquitous
players in the mechanisms of neuronal growth and maturation [6];
thereby we analyzed the activation of this receptor in neuronal
cells by assessing its phosphorylation upon binding of EGF.
Induction of differentiation with retinoic acid has been shown to
induce autophosphorylation of EGFR in Neuro-2a cells [12]. We
incubated the cells, both expressing SCD5 or empty expression
plasmid, with retinoic acid for 1 h and 48 h in serum-free DMEM
and determined the phosphorylation of Tyr1068 and Tyr1086,
two tyrosine residues that are critical for the functional activation
of EGFR. As shown in Figure 6, retinoic acid did not affect the
phosphorylation levels of Tyr residues at any incubation times in
either cell group. However, when cells were stimulated with EGF
for 5 minutes, a robust phosphorylation of Tyr1068 and Tyr1086
residues was observed in controls cells whereas SCD5-cells
displayed lower levels of EGFR phosphorylation (Figure 6),
Figure 1. Overexpression of human SCD5 increases the ratio n-7 MUFA to SFA. Neuro2a cells were stably transfected with human SCD5
cDNA in a pCDNA4 expression plasmid (SCD5 cells) or with empty plasmid alone (pCDNA4 cells). Expression of SCD5 was determined by immunoblot
analysis of cell homogenates (A). Fatty acids from total cell lipids were assessed by HPLC and ratios MUFA to SFA were calculated. B, palmitoleic acid
(16:1n-7) to palmitic acid (16:0); C, palmitoleic acid plus cis-vaccenic(18:1n-7) to palmitic acid (16:0); D, oleic acid (18:1n-9) to stearic acid (18:0). *,
p,0.05 or less.
doi:10.1371/journal.pone.0039787.g001
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the ligand-mediated activation of EGFR in neuronal cells.
Since phosphorylation of Tyr1068 and Tyr1086 are function-
ally linked to the activation of Akt and ERK signaling pathways,
next we examined whether the blunted EGF-induced activation of
EGFR seen in SCD5 expressors would be translated to its
downstream effectors. Again, treatment with retinoic acid alone
did not evoke changes in the phosphorylation status of either Akt
or ERK proteins. Incubation with EGF, in turn, induced strong
phosphorylation of both signaling proteins in pCDNA4-carrying
control cells, but this effect was noticeably attenuated in SCD5-
expressing cells (Figure 6). Altogether, these observations indicate
that fatty acids produced by SCD5 activity, or lipids acylated by
these fatty acids, negatively modulate the signaling platform
EGFRAkt/ERK upon stimulation and that this regulatory effect
may be implicated in the alterations in cell growth and
differentiation observed in cells expressing SCD5.
Modulation of canonical and non-canonical Wnt activity
by SCD5. Wnt proteins are also critical extrinsic factors that
modulate neuronal cell expansion, as well as the entry in the
differentiation program [38,39]. Wnt proteins require posttrans-
lational acylation with palmitic acid and palmitoleic acid in
conserved cysteine and serine residues, respectively for optimal
secretion and activity [40,41]. Since we observed that SCD5
expression alters the balance between SFA and MUFA, it is
conceivable that Wnt activity may be targeted for modulation by
SCD5. To examine this hypothesis, wild-type HEK293 cells were
co-transfected with cDNA encoding SCD5 or empty plasmid, plus
the luciferase reporter constructs pTOP-flash or c-Jun trans
reporter that monitor the activity of the canonical Wnt and non-
canonical Wnt pathways, respectively. For the determination of
TOP-Flash activity, Sox4 was employed as positive control for the
assay system. As expected, expression of b-catenin stimulated
canonical Wnt activity (Figure 7A). Expression of increasing
amounts of SCD5 construct in cells promoted a progressive
decrease in b-catenin-induced TOP-Flash activity (Figure 7A),
indicating that the desaturase activity is able to modify canonical
Wnt activation. Furthermore, increasing levels of transfected
SCD5 induced a parallel increase in non-canonical Wnt reporter
Figure 2. Expression of human SCD5 in Neuro2a cells modifies
glucose-mediated synthesis of lipids. Neuro2a cells stably
transfected with human SCD5 cDNA (SCD5 cells) or with empty plasmid
(pCDNA4 cells) were incubated with [U-
14C]glucose in 10%FBS DMEM
for 16 h. Total lipids were then extracted and main polar and neutral
[
14C]labeled-lipids were separated by one-dimensional thin-layer
chromatography, quantified by radiometric densitometry and normal-
ized to protein concentration. A, phosphatidylcholine (PC) and
phosphatidylethanolamine (PE); B, triacylglycerol (TAG) and cholestero-
lesters (CE). Values represent the mean 6 SD of quadruplicate samples.
*, p,0.05 or less vs control, by Student’s t test.
doi:10.1371/journal.pone.0039787.g002
Figure 3. SCD5 activity blocks retinoic acid-induced differen-
tiation of Neuro2a cells. SCD5-expressing Neuro2a cells and empty
plasmid-carrying controls (pCDNA4) were seeded in 60-mm dishes and
incubated in 10%FBS DMEM. Twenty-four hours later, media was
removed and cells were incubated with differentiation media (DMEM
supplemented with 2%FBS and10 mM retinoic acid) for 48 h. Cells were
fixed, stained with coomassie brilliant blue proliferation and photo-
graphed in a phase-contrast microscope (A). B, percentage (%) of cells
bearing one or more neurites equal to or longer than cell body
diameter.
doi:10.1371/journal.pone.0039787.g003
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transfected cells. We take these results to suggest that SCD5
activity modulates both Wnt pathways in opposite directions, an
effect that could be responsible for the alterations in cell
proliferation, differentiation, or both, seen in Neuro-2a cells.
SCD5 activity controls the synthesis and secretion of
Wnt7b and Wnt5a proteins. As mentioned above, fatty acid
binding to Wnt residues is a critical feature for the secretion of
these proteins. Recently, it was reported that a specific acylation
conserved serine residue of Wnt3a with palmitoleic acid (16:1n-7)
is a prerequisite step for the secretion of this Wnt [41]. This critical
serine residue is present in all Wnt, suggesting that the levels of
16:1n-7acylation may play a crucial role in regulation of Wnt
signaling. It is currently unknown if this 16:1-n7 is largely
originated from SCD activity or from exogenous sources.
Therefore we examined the synthesis and secretion of Wnt7b and
Wnt5a, two paradigmatic canonical and non-canonical Wnt
proteins, respectively, in cells expressing SCD5 activity. To do
so, we overexpressed either Wnt7b or Wnt5a genes tagged with
Figure 4. Effect of retinoic acid on the expression of SCD5 in
human cells. WS-1 human normal skin fibroblasts were treated with
increasing concentration of retinoic acid (RA) up to 10 mM or vehicle
DMSO (0.1% by vol) for 24 h. SCD5 and b-actin in cell homogenates
were detected by immunoblot analysis and were quantified by
densitometry (A). SH-SY5Y human neuroblastoma cells were incubated
with 20 mM RA or DMSO for 4 days and content of SCD5 protein was
assessed by Western blot (B). Levels of SCD5 were normalized using b-
actin values. Data represent the mean 6 SD of triplicate samples. *,
p,0.05 or less vs control, by Student’s t test.
doi:10.1371/journal.pone.0039787.g004 Figure 5. Expression of human SCD5 in Neuro2a cells increases
cell proliferation. Effect of retinoic acid. Neuro2a cells stably
transfected with human SCD5 cDNA (SCD5 cells) or with empty plasmid
(pCDNA4 cells) were seeded in 12-well plates and grown for different
time points up to 120 h (A). At each time point, cell proliferation was
determined by Crystal violet assay as described in Materials and
Methods. B, SCD5-expressing Neuro2a cells and their controls were
incubated with 10 mM retinoic acid or DMSO vehicle for 48 h. Cell
growth was estimated by Crystal violet staining method. Values
represent the mean 6 S.D. of triplicate determinations. *, p,0.05 or
less vs control, by Student’s t test. C, Western blot determination of
cyclin D1 and b-actin levels in control (pCDNA4) and SCD5-expressing
Neuro-2a cells incubated in serum-free DMEM with 0.1% BSA, in
presence or absence of 10mM retinoic acid (RA), for 1 h or 48 h.
doi:10.1371/journal.pone.0039787.g005
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levels of these Wnt ligands were assessed by immunoblotting. The
use of tagged constructs facilitates assessment of overexpressed
Wnt ligands by using antibodies raised against the tag peptide
without considering endogenous ligands. As shown in Figure 8A,
SCD5-expressing cells showed reduced levels of Wnt7b with
respect to vector-transfected controls. Compared to control cells,
SCD5 cells secreted lower amounts of Wnt7b, regardless of
differences in synthesis observed between control plasmid and
SCD5-transfected cells. The finding that GAPDH, a cytosolic
protein used as loading control in the immunoblot analysis, was
not detected in media rules out that different levels of secreted Wnt
were caused by cell leakage or by contamination during the
preparation of samples. As a control for specificity of the signal we
simultaneously analyzed non-transfected cells. We also analyzed
cells transfected with the empty plasmid in which Wnt ligand
construct was inserted. No signal was detected in cell lysates
neither in supernatants. Importantly, we detected reduced cellular
levels of Wnt5a but greater levels of this Wnt protein in the media
fractions of SCD5-expressing cells than in their controls
(Figure 8B), suggesting a modification of Wnt5a secretion caused
by SCD5. The fact that when Sox17 and TCF cDNA were
transfected in control and SCD5-expressing cells the levels of these
two proteins were unmodified by the presence of SCD5 activity
(data not shown) rules out a global effect of SCD5 activity on
protein production. Altogether, these experiments suggest that, by
altering the n-7 MUFA-to-SFA ratio, SCD5 activity differentially
modulates the production and secretion of canonical and non-
canonical Wnt ligands, which may account for the profiles in Wnt-
induced signaling activity observed in SCD5-expressing cells. Discussion
A complex synchronization of cell division, exit of cell cycle and
differentiation is required for the proper development of the
nervous system. The mechanisms of neuronal proliferation and
Figure 6. SCD5 expression impairs the activation of EGFR
signaling cascade. Neuro2a cells, stably transfected with SCD5 cDNA
(SCD5) or empty plasmid, were incubated in serum-free DMEM with
0.1BSA, in presence or absence of 10 mM retinoic acid (RA), for 1 h or
48 h. A group of cells incubated with RA for 48 h was stimulated with
100 ng/mL EGF for 5 minutes. Cells were harvested and homogenized
and phosphorylation of EGFR, ERK, and Akt was determined by Western
blot.
doi:10.1371/journal.pone.0039787.g006
Figure 7. SCD5 modulates the activity of both canonical and
non-canonical branches of Wnt signaling pathways. Canonical
(A) and non-canonical (B) Wnt activity was assessed by TOP-Flash and c-
jun trans-reporter assays, respectively. For these determinations, HEK
293T cells were transfected with indicated constructs. In the TOP-Flash
assay, sox4 was used as a positive control. For the c-jun trans-reporter
determination, in addition to the c-jun activator Wnt5a, pGAL4DBD,
which does not contain the activation domain, and pFC MEKK, which
activates the reporter through phosphorylation, were used as negative
and positive controls, respectively. Forty eight hours post transfection
cells were harvested and processed for luciferase assay. Values of c-Jun
trans reporter assay are the average of duplicate samples. Variability of
duplicates was less than 5%. All data are representative of three
independent experiments.
doi:10.1371/journal.pone.0039787.g007
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morphological changes that require a finely tuned modulation of
signaling pathways and lipogenic routes. The particular pattern of
expression of SCD5, with the highest levels in embryo and adult
brain [21,23], suggest that a potential role for SCD5 in the
mechanisms of proliferation and differentiation of neural cells.
Here we report that ectopic expression of SCD5 induces a drastic
phenotypical modification in Neuro2a cells, which is characterized
by a marked increase in the rate of cell replication and a drastic
suppression in the formation of branching neurites, a terminal
marker of the neuronal differentiation process.
We hypothesize that the greater rate of cell proliferation of
SCD5-expressing cells could have been caused by an acceleration
of cell cycle, a notion that is supported by the finding of much
greater levels of cyclin D1, a crucial regulator of the G1/S
transition in cell cycle progression [38], in these cells. Since exit
from cell cycle is a prerequisite for the terminal differentiation of
neurons [6], a more active cycle of cell replication could explain
the delay, or even failure, of SCD5-expressing neuronal cells in
fully developing into differentiated neurons. In this regard, we
observed that induction of the differentiation program with
retinoic acid markedly halted cell proliferation in both SCD5-
expressing and controls cells, however the effect was less marked in
the former cell group, indicating a more robust cell growth
activity.
In addition, our studies indicate that, although SCD5 may be
key factor in defining the biological fate of neuronal cells, the
desaturase is itself not targeted by the differentiation program.
This notion is supported by our findings that levels of SCD5
protein remained unchanged during the course of differentiation
of SH-SY5Y human neuroblastoma cells with retinoic acid, and in
similar incubations with retinoic acid in differentiated skin
fibroblasts. That is to say, it appears that SCD5 does not lie
downstream of the initiation in the pathway, but rather it
independently modulates the differentiation pathway.
Modifications in critical biochemical and metabolic features in
neuronal cells, such as the changes in acyl-lipid composition and
lipid biosynthesis that were detected in Neuro2a cells expressing
SCD5, could also contribute to the phenotypical perturbations
promoted by this SCD variant. As expected for a D9 desaturase,
expression of SCD5 increased the MUFA:SFA ratio in cellular
lipids, although the enrichment of lipid with MUFA was restricted
to MUFA belonging to the n-7 series, chiefly palmitoleic (16:1) and
cis-vaccenic (18:1) acids. An intriguing observation in our studies
was that the levels of oleic acid remained surprisingly unaltered in
the SCD5-expressing Neuro2a cells, suggesting a preference of the
desaturase for palmitic acid as substrate. Data from in vitro
determinations clearly showed that SCD5 was able to desaturate
both palmitic and stearic acid at approximately similar catalytic
rates [22]. We believe that the particular modifications in fatty
acid composition of SCD5-expressing cells could be attributed to
cell type-specific fatty acid biosynthetic enzymes, such as
differential elongase activity, since a similar SCD5 expression cell
model generated in mouse 3T3-L1 preadipocytes significantly
elevated the content of oleic acid (data not shown). In any case, the
higher MUFA content observed in SCD5-expressing Neuro-2a
cells may be functionally associated with their faster cell
replication, since it has been established that dividing cells, both
normal proliferating cells and cancer cells, have a critical de-
pendence on endogenously synthesized MUFA for sustaining an
active mitogenic program [15,34]. Furthermore, in cancer cells in
which SCD activity was pharmacologically blocked, addition of n-
9 or n-7 MUFA were equally effective in restoring the cell
proliferation rate [19], indicating that all MUFA exhibit pro-
growth and pro-survival functions.
Figure 8. SCD5 reduces the secretion of canonical Wnt7b
whereas it increases the secretion of non-canonical Wnt5a. To
determine the synthesis and secretion of Wnt7b and Wnt5a, Neuro2a
cells, both control (pcDNA4) and SCD5-overexpressing (SCD5), were
transiently transfected with Wnt7b- and Wnt5a- tagged constructs.
Twelve hours post-transfection, the culture media was replaced with
serum-free media. After 24 h, cell media and cells were collected and
processed for SDS-PAGE. Western blots were performed using anti V5
and anti GAPDH antibodies. This experiment is representative of three
independent assays.
doi:10.1371/journal.pone.0039787.g008
Figure 9. Hypothetical mechanisms by which SCD5 activity
modulates proliferation and differentiation in neuronal cells.
Elevated palmitoleic acid-to-palmitic acid (16:1/16:0) ratio promoted by
SCD5 expression can contributet oh i g hp r o l i f e r a t i o na n dl o w
differentiation rates in neuronal cells through multiple mechanisms,
including deactivation of EGFRAkt/ERK signaling pathways, alteration of
lipogenesis, and divergent regulation of canonical and non-canonical
Wnt pathways by affecting the secretion of Wnt ligands and/or the
modulation of intracellular Wnt activity.
doi:10.1371/journal.pone.0039787.g009
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we found that SCD5 also is implicated in the control of glucose-
mediated lipogenesis. We observed that SCD5 does not appear to
globally stimulate lipid biosynthesis from glucose, but to promote
a selective increase in the biosynthesis of phosphatidylcholine and
cholesterolesters, in parallel to decreases in the production of
phosphatidylethanolamine and triacylglycerol. This observation
suggests that unlike SCD1, which appears to control the overall
rate of lipogenesis in proliferating cells [34], SCD5 activity is
functionally linked to more specific biosynthetic routes. Impor-
tantly, the alterations in lipid biosynthesis caused by SCD5
expression could also contribute to the drastic change in the rates
of cell replication and differentiation observed in SCD5-expressing
cells. Phospholipid synthesis, particularly phosphatidylcholine, is
critically needed for propelling the progression of cell cycle [42,43]
and for avoiding the entry in the apoptotic program [44].
Therefore, the activation of the de novo phosphatidylcholine
synthesis in cells expressing ectopic SCD5 may provide abundant
lipid substrates for the formation of new cell membranes to
support their accelerated rate of cell proliferation. The activation
of phospholipid biosynthesis, especially phosphatidylcholine
though the Kennedy pathway, is also a metabolic requirement
for neurite outgrowth and branching [5,45,46]. We concede that
in the present work, for reasons of scope and focus, we did not fully
address the potential role of SCD5 activity in phospholipid
formation during neuronal differentiation; a potential contribution
of the desaturase to the regulation of this lipogenic pathway cannot
be ruled out without experimental evidence yet to be established.
The coordination of proliferation and differentiation in neurons
not only demands appropriate metabolic conditions but also the
action of extrinsic signals, such as EGF, platelet-derived growth
factor (PDGF), fibroblast growth factor 2 (FGF-2), nerve growth
factor (NGF), and Wnt proteins, among other cytokines [2-6].
Depending on the phenotypical phase to which the neuronal cell is
committed, these factors will trigger selective mechanisms that will
activate cell proliferation when expansion of the neuronal
population is required, or initiate the program of differentiation
[6]. The growth factor-mediated activation of tyrosine-kinase
receptors, as well as their downstream signaling effectors Akt,
ERK and mTOR, are key for the execution of transcriptional
mechanisms that leads to cell cycle arrest and morphological
differentiation of neurons [2,3,6,47]. Activation of EGFR,
a paradigmatic receptor that is often associated with the mitogenic
response in normal and cancer cells, is particularly critical for the
execution of these biological events in neuroblastoma cells [48,49]
and in brain astrocytes [50]. Therefore, the suppression of neurite
outgrowth in SCD5-expressing Neuro-2a cells could then be
explained by the marked blockade in the EGF-induced phosphor-
ylation/activation of EGFR and surrogate signals ERK and Akt
observed in these cells when the program of differentiation was
induced. Data from our group and others demonstrated that
SCD1 activity is critical for the functional activation of Akt and
ERK [16,51]. Our observation that SCD5 negatively regulates
these two signaling proteins upon growth factor stimulation
suggests different roles for the human SCD isoforms in the
modulation of signaling cascades. However, since our determina-
tions were restricted to a neuronal cell line, the possibility of cell-
type specific differences in the participation of SCDs in signaling
regulation cannot be ruled out at the moment.
Our results also point out to Wnt proteins as a second signaling
mechanism related to neuronal differentiation that is a target for
SCD5 activity. Our data showing that SCD5 activity activates the
non-canonical Wnt pathways while suppressing the canonical
branch of Wnt are in agreement with a previous report of a role
for the endogenous biosynthesis of MUFA in the regulation of Wnt
signals in mouse skin [52]. These authors observed that lack of
SCD1 expression led to a suppression in the expression of Lef1,
a key transcription factor involved in the regulation of canonical
Wnt/b-catenin signaling. Interestingly, ablation of Lef1 down-
regulates SCD1 expression in mouse skin [53], suggesting a positive
activation loop between MUFA and Wnt activation. Since we
found that, besides SCD1 [54], human skin fibroblasts express
significant levels of SCD5, this SCD isoform may also have a role
in the regulation of Wnt signaling in human skin tissues.
Perturbations in Wnt signaling pathways caused by ectopic
SCD5 activity may be responsible for some of the effects in the
processes of proliferation and neurite outgrowth in neuronal cells
communicated in this report since a number of studies, albeit
conflicting, have demonstrated the critical role of Wnt signaling on
neurogenesis and neuronal differentiation. In neural precursor
cells and in the developing neocortex of mice, the rate of neuronal
differentiation was positively associated to the degree of activation
of the canonical Wnt pathway [8], but in neuronal cells canonical
Wnt have been also shown to increase neuronal proliferation and
to suppress differentiation [55–57]. The discrepancies in the
function of Wnt in cell proliferation and differentiation of neuronal
cells could also arise from the fact that Wnt may activate or
deactivate both events in a time- and stage-specific manner [7,39].
Also importantly, depending on the physiological context of the
neuronal cells, a Wnt ligand may elicit either canonical or non-
canonical in these cells [58,59].
The complexity of the relationship between biological processes
like neurogenesis and neuritogenesis and Wnt activity is further
highlighted by the fact that posttranslational modifications of Wnt
proteins profoundly affect their functional properties. For instance,
Wnt-3a is targeted for S-palmitoylation in its Cys77 residue, an
event that is critical for signaling activation [41]. More recently,
Galli and Burrus [60] reported that acylation of Wnt1 in specific
residues affects both Wnt signaling branches, showing that binding
of palmitoleic acid to S224 preferentially signals via the ß-catenin
pathway while acylation with palmitic acid (palmitoylation) on
C93 primarily impacts the non-canonical, ß-catenin-independent
pathway.
Our experiments provide evidence that SCD5 modulates not
only the activity of Wnt signaling pathways but also the levels of
secreted of Wnt ligands, suggesting an additional regulatory
mechanism by which the desaturase may control cell proliferation,
differentiation, or both. The observation that SCD5 activity
enhances the secretion of non-canonical Wnt5a while it reduces
the synthesis and, consequently, the secretion of canonical Wnt7b
may partly explain the finding of similar changes in the activity in
both branches of Wnt signaling in SCD5-expressing cells. The
mechanisms by which SCD5 activity controls the production and
release of Wnt are currently unknown. Synthesis, intracellular
transport and secretion of Wnt are tightly regulated events that
also depend on posttranslational modification by fatty acid
acylation. Through a battery of elegant experiments, Takada et
al. [41] demonstrated that Wnt-3a is specifically acylated on
Ser209 with palmitoleic acid (16:1 n-7) and that this modification
is essential for the intracellular transport and secretion of this Wnt.
These authors reported that Ser209 is part of an amino acid
sequence that is highly conserved among the members of the Wnt
family, suggesting that other Wnt proteins may be modified,
structurally and functionally, by palmitoleyl acid (16:1 n-7)
acylation. In most acylated proteins, an unsaturated fatty acid
could conceivably be replaced by a saturated fatty acid in a residue
targeted for acylation, hence in SCD5-expressing cells the
abundance of palmitoleic acid may displace palmitic acid from
SCD5 Controls Neuronal Growth and Differentiation
PLoS ONE | www.plosone.org 10 June 2012 | Volume 7 | Issue 6 | e39787the acylation site in Wnt proteins, potentially modifying their
transport, their rate of secretion, or both. However, although it is
clear that SCD5 expression alters the homeostatic control of Wnt
proteins, at this early stage in the investigation, the questions of
whether SCD5-mediated modification of Wnt synthesis and
secretion is related to a potential change in their acylation, and
whether changing levels of Wnt are responsible for the alterations
in the activation of Wnt pathways in SCD5-expressing cells await
further experimental confirmation. Finally, given the mounting
evidence suggesting a mechanistic association of abnormal Wnt
signaling with Alzheimer’s and Parkinson’s diseases [61], our
findings suggest that SCD5 may be a molecular link between
signaling and lipogenic pathways mechanisms and these neurode-
generative conditions.
In conclusion, the present study provides the first evidence that
human SCD5 activity is implicated in the regulation of critical
biological functions in neuronal cells. Our findings imply that, by
modulating fatty acid composition, lipogenesis and intracellular
signaling, SCD5 controls the rate of replication and differentiation
of neuronal cells (Figure 9). We observed that the constitutive
expression of human SCD5 promotes a shift in the fatty acid
composition in lipids of neuronal cells, which was characterized by
elevated levels of n-7 MUFA with a concomitant reduction in
SFA. These modifications in the fatty acid pattern were
accompanied by lipogenic alterations, such as the change in the
rate of synthesis of phospholipids, which are known to affect cell
growth, survival and differentiation. Remarkably, SCD5 expres-
sion promotes a profound deregulation of EGF’s intracellular
signaling mechanisms. We observed that SCD5 expression
suppresses the ligand-induced activation of the EGFRAkt/ERK
signaling platform. SCD5 activity also reduces the activation of
canonical Wnt signaling whereas it stimulates the non-canonical
branch of the Wnt pathway. These activity changes could be
directly related to the perturbations in the synthesis and secretion
of Wnt proteins observed in SCD5-expressing neuronal cells. We
also found that SCD5 expression accelerates cell cycle progression
while suppressing the program of differentiation, indicating that
the fate of neuronal cells is, ultimately, determined by the activity
of the desaturase. Lastly, our studies suggest a value for SCD5 as
a potential target for clinical interventions in poorly-treated
neurological diseases such as brain cancer, Alzheimer and other
neurodegenerative conditions.
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